Format

Send to

Choose Destination
Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:375-398. doi: 10.1146/annurev-pharmtox-010716-104936.

Autophagy: A Druggable Process.

Author information

1
Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR 8253, F-75993 Paris, France; email: patrice.codogno@inserm.fr.
2
Université Paris Descartes-Sorbonne Paris Cité, F-75012 Paris, France.
3
Université Paris Diderot-Sorbonne Paris Cité, F-75993 Paris, France.

Abstract

Macroautophagy (hereafter called autophagy) is a vacuolar, lysosomal pathway for catabolism of intracellular material that is conserved among eukaryotic cells. Autophagy plays a crucial role in tissue homeostasis, adaptation to stress situations, immune responses, and the regulation of the inflammatory response. Blockade or uncontrolled activation of autophagy is associated with cancer, diabetes, obesity, cardiovascular disease, neurodegenerative disease, autoimmune disease, infection, and chronic inflammatory disease. During the past decade, researchers have made major progress in understanding the three levels of regulation of autophagy in mammalian cells: signaling, autophagosome formation, and autophagosome maturation and lysosomal degradation. As we discuss in this review, each of these levels is potentially druggable, and, depending on the indication, may be able to stimulate or inhibit autophagy. We also summarize the different modulators of autophagy and their potential and limitations in the treatment of life-threatening diseases.

KEYWORDS:

activators; autophagosome; disease; inhibitors; lysosome; macroautophagy

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center